NO912870D0 - Blandinger for tildeling av medikamenter. - Google Patents
Blandinger for tildeling av medikamenter.Info
- Publication number
- NO912870D0 NO912870D0 NO1991912870A NO912870A NO912870D0 NO 912870 D0 NO912870 D0 NO 912870D0 NO 1991912870 A NO1991912870 A NO 1991912870A NO 912870 A NO912870 A NO 912870A NO 912870 D0 NO912870 D0 NO 912870D0
- Authority
- NO
- Norway
- Prior art keywords
- medicines
- allocation
- mixtures
- composition
- active compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898904370A GB8904370D0 (en) | 1989-02-25 | 1989-02-25 | Liquid delivery compositions |
| PCT/GB1990/000291 WO1990009780A1 (en) | 1989-02-25 | 1990-02-23 | Drug delivery compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO912870D0 true NO912870D0 (no) | 1991-07-23 |
| NO912870L NO912870L (no) | 1991-07-23 |
| NO301692B1 NO301692B1 (no) | 1997-12-01 |
Family
ID=10652342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO912870A NO301692B1 (no) | 1989-02-25 | 1991-07-23 | Bærersubstans for bruk med farmakologisk aktiv forbindelse og fremgangsmåte for fremstilling av en blanding omfattende en slik bærer |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0460020B2 (no) |
| JP (1) | JP3306779B2 (no) |
| AT (1) | ATE104545T1 (no) |
| CA (1) | CA2045472C (no) |
| DE (1) | DE69008346T3 (no) |
| DK (1) | DK0460020T3 (no) |
| ES (1) | ES2055904T5 (no) |
| GB (1) | GB8904370D0 (no) |
| NO (1) | NO301692B1 (no) |
| WO (1) | WO1990009780A1 (no) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2099376A1 (en) * | 1991-01-03 | 1992-07-04 | Henry E. Auer | Stabilization of proteins by cationic biopolymers |
| KR100419037B1 (ko) | 1994-03-07 | 2004-06-12 | 넥타르 테라퓨틱스 | 폐를통한인슐린의전달방법및그조성물 |
| US6054462A (en) * | 1994-04-13 | 2000-04-25 | Janssen Pharmaceutica, N.V. | Intranasal antimigraine compositions |
| HRP950149A2 (en) * | 1994-04-13 | 1997-06-30 | Janssen Pharmaceutica Nv | Intranasal antimigrene composition |
| GB9416884D0 (en) * | 1994-08-20 | 1994-10-12 | Danbiosyst Uk | Drug delivery compositions |
| GB9419979D0 (en) * | 1994-10-04 | 1994-11-16 | Medeva Holdings Bv | Vaccine compositions |
| SE9403905D0 (sv) * | 1994-11-14 | 1994-11-14 | Astra Ab | New formulations |
| US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| JP3098401B2 (ja) * | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
| GB9522351D0 (en) * | 1995-11-01 | 1996-01-03 | Medeva Holdings Bv | Vaccine compositions |
| GB9525083D0 (en) | 1995-12-07 | 1996-02-07 | Danbiosyst Uk | Vaccine compositions |
| US6184037B1 (en) | 1996-05-17 | 2001-02-06 | Genemedicine, Inc. | Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| JP3020141B2 (ja) * | 1996-10-07 | 2000-03-15 | 株式会社富士薬品 | 経鼻投与用製剤 |
| US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| GB9700624D0 (en) | 1997-01-14 | 1997-03-05 | Danbiosyst Uk | Drug delivery composition |
| US6730735B2 (en) | 1997-07-03 | 2004-05-04 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Conjugate of polyethylene glycol and chitosan |
| GB9725084D0 (en) | 1997-11-28 | 1998-01-28 | Medeva Europ Ltd | Vaccine compositions |
| PT1093818E (pt) * | 1998-07-08 | 2006-07-31 | Kirin Amgen Inc | Preparacao em po para administracao nas mucosas contendo um medicamento polimerico |
| GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
| ES2295391T3 (es) | 2001-08-16 | 2008-04-16 | Cmp Therapeutics Limited | Microparticulas de quitina y sus usos medicos. |
| KR20040071678A (ko) * | 2001-09-28 | 2004-08-12 | 유니버시티 오브 사우스 플로리다 | Ｒｓｖ 유전자 발현 백신 |
| US7666876B2 (en) | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
| CA2484251C (en) | 2002-04-30 | 2015-06-23 | University Of South Florida | Materials and methods for inhibition of respiratory syncytial virus infection |
| US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
| US7595303B1 (en) | 2002-09-05 | 2009-09-29 | University Of South Florida | Genetic adjuvants for immunotherapy |
| GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
| GB0310919D0 (en) | 2003-05-13 | 2003-06-18 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
| GB0315632D0 (en) | 2003-07-04 | 2003-08-13 | West Pharm Serv Drug Res Ltd | Pharmaceutical formulations |
| EP1734938B1 (en) | 2004-03-26 | 2012-06-20 | Universita' Degli Studi Di Parma | Insulin highly respirable microparticles |
| US8399025B2 (en) | 2004-06-04 | 2013-03-19 | Board Of Regents, The University Of Texas System | Polyamine modified particles |
| EP1797870A1 (en) * | 2005-12-14 | 2007-06-20 | The Jordanian Pharmaceutical Manufacturing Co. | Oral delivery of protein drugs using microemulsion |
| EP2034954B1 (en) | 2006-03-30 | 2019-02-20 | Engene, Inc. | Non-viral compositions and methods for transfecting gut cells in vivo |
| CN101472598A (zh) | 2006-06-20 | 2009-07-01 | Cmp医疗有限公司 | 包含壳多糖微粒的组合物及其医药用途 |
| CA2677838C (en) | 2007-02-11 | 2017-08-01 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| MX2010001723A (es) * | 2007-08-17 | 2010-04-30 | Amgen Inc | Formulaciones de anticuerpos y moleculas de fusion-fc usando policationes. |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| GB0812742D0 (en) | 2008-07-11 | 2008-08-20 | Critical Pharmaceuticals Ltd | Process |
| EP2414560B1 (de) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Verfahren zur beschichtung einer oberfläche eines bauteils |
| WO2010133294A2 (de) | 2009-05-18 | 2010-11-25 | Boehringer Ingelheim International Gmbh | Adapter, inhalationseinrichtung und zerstäuber |
| CN102686260B (zh) | 2009-11-25 | 2014-10-01 | 贝林格尔.英格海姆国际有限公司 | 喷雾器 |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| JP5658268B2 (ja) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| RS58985B1 (sr) | 2012-03-15 | 2019-08-30 | Acraf | Katjonski polimeri na bazi glikogena |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| WO2014055825A1 (en) | 2012-10-04 | 2014-04-10 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | A formulation of mycobacterial components as an adjuvant for inducing th17 responses |
| US10258682B2 (en) | 2013-01-16 | 2019-04-16 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Attenuated chlamydia vaccine |
| US9744313B2 (en) | 2013-08-09 | 2017-08-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| UA121114C2 (uk) | 2014-05-07 | 2020-04-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Небулайзер, індикаторний пристрій і контейнер |
| EP3139979B1 (en) | 2014-05-07 | 2023-07-05 | Boehringer Ingelheim International GmbH | Unit, nebulizer and method |
| ES2874029T3 (es) | 2014-05-07 | 2021-11-04 | Boehringer Ingelheim Int | Nebulizador |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3200766A1 (de) * | 1981-01-14 | 1982-09-16 | Toyo Jozo Kk | Praeparat mit ausgezeichneter absorptionseigenschaft |
-
1989
- 1989-02-25 GB GB898904370A patent/GB8904370D0/en active Pending
-
1990
- 1990-02-23 ES ES90903612T patent/ES2055904T5/es not_active Expired - Lifetime
- 1990-02-23 DK DK90903612.1T patent/DK0460020T3/da active
- 1990-02-23 CA CA002045472A patent/CA2045472C/en not_active Expired - Lifetime
- 1990-02-23 EP EP90903612A patent/EP0460020B2/en not_active Expired - Lifetime
- 1990-02-23 DE DE69008346T patent/DE69008346T3/de not_active Expired - Lifetime
- 1990-02-23 JP JP50363790A patent/JP3306779B2/ja not_active Expired - Lifetime
- 1990-02-23 AT AT9090903612T patent/ATE104545T1/de not_active IP Right Cessation
- 1990-02-23 WO PCT/GB1990/000291 patent/WO1990009780A1/en active IP Right Grant
-
1991
- 1991-07-23 NO NO912870A patent/NO301692B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69008346T3 (de) | 1998-01-08 |
| ES2055904T5 (es) | 1998-01-01 |
| JP3306779B2 (ja) | 2002-07-24 |
| EP0460020B2 (en) | 1997-09-17 |
| EP0460020A1 (en) | 1991-12-11 |
| GB8904370D0 (en) | 1989-04-12 |
| NO301692B1 (no) | 1997-12-01 |
| CA2045472A1 (en) | 1990-08-26 |
| DE69008346D1 (de) | 1994-05-26 |
| EP0460020B1 (en) | 1994-04-20 |
| NO912870L (no) | 1991-07-23 |
| ES2055904T3 (es) | 1994-09-01 |
| WO1990009780A1 (en) | 1990-09-07 |
| ATE104545T1 (de) | 1994-05-15 |
| DK0460020T3 (da) | 1994-05-16 |
| CA2045472C (en) | 2000-01-04 |
| DE69008346T2 (de) | 1994-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO912870L (no) | Blandinger for tildeling av medikamenter. | |
| AU3881989A (en) | New solid porous unitary form comprising micro-particles and/or nano-particles, and its preparation | |
| BR9911070A (pt) | Sistema de liberação de droga compreendendo uma matéria-prima de medicamento sólido acentuadamente compacto | |
| ES2162927T3 (es) | Formulacion para la aplicacion por inhalacion. | |
| ATE332126T1 (de) | Geschmacksmaskierte pharmazeutische zusammensetzungen | |
| FI870155A (fi) | Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi | |
| ATE128863T1 (de) | Arzneimittelformulierungen mit verzögerter wirkstoffabgabe. | |
| JO1502B1 (en) | New pharmacy vehicles | |
| NO175763C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat hvor DL-tryptofan, eventuelt i kombinasjon med fumarsyre, anvendes som hjelpestoffer | |
| KR910011244A (ko) | 로젠지제 | |
| MY101784A (en) | Novel pharmacological compounds | |
| DE3765243D1 (de) | Ibuprofen und codein enthaltende, stabile, feste arzneimittel. | |
| BR9809268A (pt) | Unidade de dosagem farmacêutica, processo para fabricação da mesma, e, uso de um produto de amido como um veìculo para unidades de dosagem farmacêutica compreendendo tibolona | |
| MY102411A (en) | Nasal solutions | |
| GB2021409A (en) | Pharmaceutical composition | |
| GR3002765T3 (en) | New pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient | |
| SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
| BR0012775A (pt) | Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido | |
| DE69225053T2 (de) | Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung | |
| EE9600202A (et) | Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm | |
| BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
| ES2058065T3 (es) | Composiciones farmaceuticas que contienen fragmentos de acth para la terapia de condiciones de shock y de insuficiencias respiratorias y cardiocirculatorias. | |
| KR920016104A (ko) | 노인성 특발적 백내장 약제 제조를 위한 칼시토닌의 국소적용 용도 및 이의 약제학적 조성물 | |
| TH6020B (th) | สูตรผสมเมนาไดโอนไบซัลโฟท์ที่ได้ทำให้เสถียร และการเตรียมสูตรผสมเหล่านี้ | |
| KR880002537A (ko) | 생약제제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |